Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
What were the most significant global policy documents published in medtech last year? Here’s Market Pathways’ top 10 guidelines, regulations, notices, and other key items issued in 2025, countdown style.
Access to data and the use of it are increasingly important components of corporate strategy. How it is valued, structured and owned differentiates companies and raises challenges in dealmaking. A panel organized this month by Medtech Strategist for Weill Cornell Medicine’s BioVenture eLab Accelerator sought clarity, and an innovative, focused venture capitalist separately gives her firm’s creative investment thesis.
Across-the-board streamlining is proposed. Excerpted from Pathways’ Picks December 17: EU Overhaul, FDA Real-World Evidence Shift, and More Updates in End-of-Year Global Policy Bonanza.